AQR Capital Management - SYNERGY PHARMACEUTICALS DEL ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q2 2017$447,000
-2.6%
100,440
+1.9%
0.00%0.0%
Q1 2017$459,000
+190.5%
98,586
+280.1%
0.00%
Q4 2016$158,000
+10.5%
25,9400.0%0.00%
Q3 2016$143,000
+44.4%
25,9400.0%0.00%
Q2 2016$99,000
-34.0%
25,940
-52.3%
0.00%
Q1 2016$150,000
-65.6%
54,325
-29.4%
0.00%
-100.0%
Q4 2015$436,000
+10.1%
76,915
+2.9%
0.00%0.0%
Q3 2015$396,000
+560.0%
74,746
+408.1%
0.00%
Q2 2014$60,000
-52.4%
14,711
-38.0%
0.00%
Q1 2014$126,000
-5.3%
23,7110.0%0.00%
Q4 2013$133,000
-2.9%
23,711
-21.0%
0.00%
Q3 2013$137,000
-38.6%
30,011
-41.7%
0.00%
-100.0%
Q2 2013$223,00051,5110.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2023
NameSharesValueWeighting ↓
CVI Holdings, LLC 1,767,858$3,235,0004.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,505,809$2,726,0001.06%
Nantahala Capital Management 11,578,568$21,189,0000.96%
Hikari Power Ltd 2,000,000$3,660,0000.43%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,376,708$2,519,0000.20%
KNOTT DAVID M 225,400$412,0000.17%
Truepoint, Inc. 37$20,000,0000.16%
Clear Harbor Asset Management, LLC 283,560$519,0000.10%
Malaga Cove Capital, LLC 97,266$178,0000.10%
Lehman Financial Resources, Inc. 70,800$129,0000.07%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders